Q4 2024 saw solid sequential recovery, with 3.1% organic net sales growth and strong order intake, especially in North America. Profitability improved, cash conversion remained robust, and a positive outlook for 2025 is supported by a larger order book and new product launches.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.